Cargando…

Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors

Striking evidence associates cancer stem cells (CSCs) to the high recurrence rates and poor survival of patients with muscle-invasive bladder cancer (BC). However, the prognostic implication of those cells in risk stratification is not firmly established, mainly due to the functional and phenotypic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira-Teixeira, Margarida, Parada, Belmiro, Rodrigues-Santos, Paulo, Alves, Vera, Ramalho, José S., Caramelo, Francisco, Sousa, Vitor, Reis, Flávio, Gomes, Célia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742170/ https://www.ncbi.nlm.nih.gov/pubmed/26452033

Ejemplares similares

Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells
por: Ferreira-Teixeira, Margarida, et al.
Publicado: (2016)

Omega-3 Fatty Acids Inhibit Tumor Growth in a Rat Model of Bladder Cancer
por: Parada, Belmiro, et al.
Publicado: (2013)

Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory Properties
por: Parada, Belmiro, et al.
Publicado: (2012)

Preventive but Not Curative Efficacy of Celecoxib on Bladder Carcinogenesis in a Rat Model
por: Sereno, José, et al.
Publicado: (2010)

Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model
por: Fernandes, João C., et al.
Publicado: (2012)

Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
por: Magalhães, Joana C, et al.
Publicado: (2023)

Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model
por: Sereno, José, et al.
Publicado: (2012)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

One Step Nucleic Acid Amplification (OSNA) Lysate Samples Are Suitable to Establish a Transcriptional Metastatic Signature in Patients with Early Stage Hormone Receptors-Positive Breast Cancer
por: Gante, Inês, et al.
Publicado: (2022)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Protein Interactome of Muscle Invasive Bladder Cancer
por: Bhat, Akshay, et al.
Publicado: (2015)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Integrated Multi-Omics Signature Predicts Survival in Head and Neck Cancer
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2022)

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
por: Ferreira, Liliana, et al.
Publicado: (2010)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer
por: Zhou, Lin, et al.
Publicado: (2021)

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
por: Dalla, Emiliano, et al.
Publicado: (2022)

Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
por: Jiang, Kan, et al.
Publicado: (2022)

Identification of circular RNA signature in bladder cancer
por: Yang, Xiao, et al.
Publicado: (2017)

Are we following the guidelines on non-muscle invasive bladder cancer?
por: Reis, Leonardo Oliveira, et al.
Publicado: (2016)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer
por: Dancik, Garrett M., et al.
Publicado: (2015)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer
por: Chen, Weitian, et al.
Publicado: (2022)

Using Data Mining to Assist in Predicting Reproductive Outcomes Following Varicocele Embolization
por: Sousa, Ana Paula, et al.
Publicado: (2021)

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
por: Zhang, Ge, et al.
Publicado: (2014)

Usefulness of the Urine Methylation Test (Bladder EpiCheck(®)) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study
por: Peña, Karla B., et al.
Publicado: (2022)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Using Resistin, glucose, age and BMI to predict the presence of breast cancer
por: Patrício, Miguel, et al.
Publicado: (2018)

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
por: Tholomier, Côme, et al.
Publicado: (2020)

Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer
por: Jiang, Xiumei, et al.
Publicado: (2016)

Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures
por: Huang, Xiaoli, et al.
Publicado: (2020)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ht81la3k8lrdl23lbpri5nl5id